医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

2022 International Symposium on Human Identification (ISHI) Keynote DeNeen L. Brown Outlines Search for Victims of 1921 Tulsa Race Massacre

2022年08月09日 PM08:00
このエントリーをはてなブックマークに追加


 

MADISON, Wis.

More than 1000 forensic DNA experts and law enforcement professionals from around the world will gather at the International Symposium on Human Identification (ISHI) October 31 – November 3 in Washington D.C. Keynote speaker DeNeen L. Brown, a reporter at The Washington Post, will discuss the Red Summer of 1919, when a reign of racist massacres swept more than 25 US cities, and the 1921 Tulsa Race Massacre. Brown’s reporting prompted the City of Tulsa to reopen an investigation into the search for mass graves of Black people killed during the massacre. In 2020, scientists discovered a mass grave in the city’s public cemetery.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220802005974/en/

The International Symposium on Human Identification (ISHI) will take place October 31 - November 3 in Washington D.C. This annual meeting is the world's largest conference focused on technologies, policies and innovations in forensic DNA analysis for human identification.

The International Symposium on Human Identification (ISHI) will take place October 31 – November 3 in Washington D.C. This annual meeting is the world’s largest conference focused on technologies, policies and innovations in forensic DNA analysis for human identification.

“These pieces of history are so tragic and horrible, and they impacted real, live people,” Brown says. “It is my hope that the forensic scientists in the audience are able to connect with these missing pieces of history…and then leave that place inspired to do the work, to pursue justice, to connect the dots in history.”

WHAT: ISHI is a forum for sharing emerging technologies, changing policies and advances in forensic DNA science. Promega Corporation, a leader in providing innovative solutions and technical support to the life sciences industry, including products for DNA-based human identification, has sponsored ISHI for 33 years.

In addition to the keynote, ISHI33 will cover:

  • Use of rapid DNA to identify victims from the Surfside Condominium collapse
  • How the Innocence Project is bringing justice to the wrongfully convicted
  • Victim identification in the field from the conflict in Ukraine
  • Best practices and application of forensic genetic genealogy
  • The DNA Justice Project, preventing sexual assaults by clearing DNA backlogs
  • Project Prism, identifying Toronto’s missing men

WHEN: October 31 – November 3, 2022

WHERE: Washington D.C; Gaylord National Resort & Convention Center

WHO: ISHI attracts forensic experts representing 40+ countries and a variety of professions including criminalists, research scientists, lab directors, CODIS analysts and forensic scientists to discuss the latest advances in forensic DNA analysis. Media are invited to attend and must pre-register.

WEB: Visit www.ishinews.com for agenda, registration and updates.

About Promega Corporation

This symposium for forensic experts and suppliers is offered through Promega Corporation, a leader in providing innovative solutions and technical support to the life sciences industry, including products for DNA-based human identification. The company’s portfolio of over 4,000 products support a range of life science work across areas such as cell biology; DNA, RNA and protein analysis; drug development; human identification and molecular diagnostics. For over 40 years these tools and technologies have grown in their application and are used today by scientists and technicians in labs for academic and government research, forensics, pharmaceuticals, clinical diagnostics and agricultural and environmental testing. Promega is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information, visit www.promega.com and connect with Promega on Twitter, LinkedIn, Facebook, Instagram and the Promega Connections blog.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220802005974/en/

CONTACT

Penny Patterson

VP, Corporate Affairs

Promega Corporation

Phone: (608) 274-4330

E-mail: penny.patterson@promega.com

同じカテゴリーの記事 

  • MHRA Issues Notice of Acceptance for POLARIS-AD, a Phase 3 Early Alzheimer’s Disease Trial Sponsored by AriBio Co., Ltd.
  • Celltrion在第19届ECCO大会上公布了皮下注射英夫利西单抗(CT-P13 SC)治疗炎症性肠病(IBD)的两年新数据
  • セルトリオン、第19回 ECCO会議で炎症性腸疾患(IBD)における皮下インフリキシマブ(CT-P13 SC)の2年間の新データを発表
  • Neuraptive Therapeutics, Inc. 公布了NTX-001在2期NEUROFUSE研究中表现积极的24周数据,强化了之前宣布的概念验证12周数据结果
  • ニューラプティブ・セラピューティクス、NTX-001に関する第2相NEUROFUSE研究における24週間の良好なデータを発表し、以前に発表した概念実証の12週間データを補強